Subtype
Malignant Large Intestinal Neoplasm
CI-CAN-00003173Explore in graph →
1,622 active trials21 approved drugs383 evidence items
- NCIt
- C215202
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003173Explore in graph →
Clinical trials
7,502 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (742)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05241574 | Planned Non-operative Management for Rectal Cancer | unknown | Phase 2 | 23 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Feb 15, 2022 | clinicaltrials |
| NCT05235607 | Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors | unknown | Phase 1 | 60 | Sichuan UniversityOTHER | 1 | Feb 11, 2022 | clinicaltrials |
| NCT05232721 |
| Evaluation of a Point-of-care Testing Instrument for Fecal Immunochemical Test |
| unknown |
| — |
| 275 |
| Shandong UniversityOTHER |
| 1 |
| Feb 10, 2022 |
| clinicaltrials |
| NCT05233540 | Circulating Biomarkers in Patients With Anal Cancer Treated With Induction Chemotherapy | unknown | — | 60 | Aarhus University HospitalOTHER | 1 | Feb 10, 2022 | clinicaltrials |
| NCT05201872 | Bacteriological Differences Between Transanal and Laparoscopic Total Mesorectal Excision for Rectal Cancer. | unknown | — | 216 | Yanhong DengOTHER | 1 | Feb 7, 2022 | clinicaltrials |
| NCT05201885 | Oncological Differences Between Transanal and Laparoscopic Total Mesorectal Excision for Rectal Cancer. | unknown | — | 192 | Yanhong DengOTHER | 1 | Feb 3, 2022 | clinicaltrials |
| NCT05221957 | Effects of Preoperative Correction of Anemia With Intravenously Iron in Colorectal Cancer Patients. | unknown | N/A | 200 | Zealand University HospitalOTHER | 0 | Feb 3, 2022 | clinicaltrials |
| NCT04790227 | MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer | unknown | — | 50 | Assiut UniversityOTHER | 1 | Feb 1, 2022 | clinicaltrials |
| NCT05200611 | Fecal Immunochemical Test for Advanced Adenoma Detection in Colorectal Cancer Screening | unknown | — | 5,000 | Shandong UniversityOTHER | 1 | Jan 21, 2022 | clinicaltrials |
| NCT02786329 | Anesthesia and Postoperative Outcome in Colorectal Cancer Patients | unknown | Early Phase 1 | 450 | Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian FodorOTHER | 1 | Jan 20, 2022 | clinicaltrials |
| NCT05200299 | mFOLFOXIRI Compared to mFOLFOX6 or CapeOx as Adjuvant Chemotherapy for Stage IIIB or IIIC Colorectal Cancer | unknown | Phase 2 | 100 | First Affiliated Hospital of Wenzhou Medical UniversityOTHER | 1 | Jan 20, 2022 | clinicaltrials |
| NCT04728139 | Assessment of Glypican 3 as Apredictive Marker in Colorectal Cancer Patients | unknown | N/A | 90 | Assiut UniversityOTHER | 0 | Jan 13, 2022 | clinicaltrials |
| NCT02279771 | Transanal Reinforcement of Low Rectal Anastomosis in Rectal Cancer Surgery(LessStoReS) | unknown | N/A | 140 | Donato F AltomareNETWORK | 1 | Jan 11, 2022 | clinicaltrials |
| NCT03581344 | BReak Interval Delayed Surgery for Gastrointestinal Extraperitoneal Rectal Cancer(BRIDGE) | unknown | N/A | 148 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Jan 11, 2022 | clinicaltrials |
| NCT05172713 | Outcomes of Patients Who Had an Incomplete Colonoscopy After a Positive Fecal Immunological Test(ColonoScopy) | unknown | — | 100 | University Hospital, Strasbourg, FranceOTHER | 1 | Dec 29, 2021 | clinicaltrials |
| NCT05161585 | Evaluation of Circulating Tumor DNA Guided Surveillance Strategy of Stage III Colorectal Cancer: an Open, Prospective, Randomized Controlled Cohort Study | unknown | N/A | 316 | Fudan UniversityOTHER | 1 | Dec 17, 2021 | clinicaltrials |
| NCT05156307 | Accuracy and Predictive Values for Colorectal Cancer of Quantitative FIT in Symptomatic Patients in Primary Care | unknown | — | 2,500 | Region Örebro CountyOTHER | 1 | Dec 14, 2021 | clinicaltrials |
| NCT03597126 | Short Term Outcomes of Robotic-assisted Intersphincteric Resection for Low Rectal Cancer(R-ISR) | unknown | N/A | 100 | Southwest Hospital, ChinaOTHER | 1 | Dec 9, 2021 | clinicaltrials |
| NCT05130021 | A Clincal Study of Max-40279-01 in Patients With Advanced Colorectal Cancer | unknown | Phase 2 | 130 | Maxinovel Pty., Ltd.INDUSTRY | 1 | Dec 6, 2021 | clinicaltrials |
| NCT04078828 | PR in Endoscopic LAR for Rectal Cancer | unknown | N/A | 10 | Southwest Hospital, ChinaOTHER | 1 | Nov 30, 2021 | clinicaltrials |
| NCT05131243 | the Role of ctDNA in Predicting the Recurrence Risk of Colorectal Cancer | unknown | N/A | 100 | Fujian Cancer HospitalOTHER_GOV | 0 | Nov 23, 2021 | clinicaltrials |
| NCT05131763 | NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors | unknown | Phase 1 | 3 | Fudan UniversityOTHER | 1 | Nov 23, 2021 | clinicaltrials |
| NCT05125393 | Evaluation the Safety of Indocyanine Green Guided Treatment of Henle Trunk(SIGHELC) | unknown | N/A | 128 | Shanghai East HospitalOTHER | 0 | Nov 18, 2021 | clinicaltrials |
| NCT04070898 | Prospective, Controlled, Randomized Multicentric Study on the Management of the Vesical Catheter in Colon Surgery. | unknown | N/A | 416 | Corporacion Parc TauliOTHER | 1 | Nov 16, 2021 | clinicaltrials |
| NCT04456933 | Intracorporeal Anastomosis in Laparoscopic Left Colectomy. Cohort Comparative Study(RIAL-COLECTOMY) | unknown | — | 148 | Corporacion Parc TauliOTHER | 1 | Nov 16, 2021 | clinicaltrials |
| NCT04764006 | Surufatinib Combined With Sintilimab for Advanced MSS-Type Colorectal Cancer : a Phase II Study | unknown | Phase 2 | 10 | Fujian Cancer HospitalOTHER_GOV | 1 | Nov 4, 2021 | clinicaltrials |
| NCT03218423 | Longitudinal Performance of Epi proColon(PERT) | unknown | — | 4,500 | Epigenomics, IncINDUSTRY | 1 | Nov 1, 2021 | clinicaltrials |
| NCT04065984 | Body Composition Manipulation in CoLorectal cancEr (BiCyCLE): Neuromuscular Electrical Stimulation (NMES)(BiCyCLE-NMES) | unknown | N/A | 46 | London North West Healthcare NHS TrustOTHER | 1 | Oct 29, 2021 | clinicaltrials |
| NCT04582981 | Fruquintinib and Raltitrexed Versus Fruquintinib Monotherapy in Advanced Colorectal Cancer | unknown | Phase 2 | 136 | Fudan UniversityOTHER | 1 | Oct 26, 2021 | clinicaltrials |
| NCT05077839 | Trifluridine/Tipiracil Combined With Oxaliplatin and Bevacizumab Versus XELOX Plus Bevacizumab in mCRC(TOBACO) | unknown | Phase 2 | 184 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Oct 25, 2021 | clinicaltrials |
| NCT05086601 | A Cohort of Molecular Characteristics and Prognosis of Colorectal Cancer | unknown | — | 15,000 | Fudan UniversityOTHER | 1 | Oct 21, 2021 | clinicaltrials |
| NCT04948762 | A Contemporary Review of Surgical Approaches in Pelvic Exenterative Surgery | unknown | — | 1,000 | St Vincent's University Hospital, IrelandOTHER | 1 | Oct 20, 2021 | clinicaltrials |
| NCT05068206 | A Clinical Study to Compare the Efficacy and Safety of AK105 Plus Anlotinib and Capecitabine/Oxaliplatin (CapeOx) , Anlotinib Plus CapeOx, Bevacizumab Plus CapeOx | unknown | Phase 2 | 120 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Oct 20, 2021 | clinicaltrials |
| NCT03146338 | Prophylaxis of Magnesium-rich Mineral Water to Prevent Hypomagnesemia Induced by an Anti-EGFR (OPTIMAG)(OPTIMAG) | unknown | N/A | 106 | WepromOTHER | 1 | Oct 15, 2021 | clinicaltrials |
| NCT05079438 | Dendrobium Huoshanense Suppository in Rectal Cancer | unknown | Phase 3 | 168 | Zhejiang Cancer HospitalOTHER | 1 | Oct 15, 2021 | clinicaltrials |
| NCT05079503 | Gut Microbiome and Its Immune Modulation in Locally Advanced Rectal Cancer | unknown | N/A | 40 | Korean Cancer Study GroupOTHER | 0 | Oct 15, 2021 | clinicaltrials |
| NCT05077358 | Intracorporeal Versus Extracorporeal Anastomosis In Laparoscopic Right Colon Resection | unknown | N/A | 241 | Yonsei UniversityOTHER | 1 | Oct 14, 2021 | clinicaltrials |
| NCT05076305 | PelvEx 4: Advanced Pelvic Malignancy and the Role of the Multi-disciplinary Team Meeting | unknown | — | 12 | St Vincent's University Hospital, IrelandOTHER | 1 | Oct 13, 2021 | clinicaltrials |
| NCT01688232 | The Immunoscore as a Prognostic Marker for Patients With a Colorectal Cancer(IMMUCOL) | unknown | — | 459 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Oct 12, 2021 | clinicaltrials |
| NCT02274753 | Personalizing Colorectal Cancer Medicine (ImmuCol2)(ImmuCol2) | unknown | — | 220 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Oct 12, 2021 | clinicaltrials |
| NCT04774757 | Systemic Therapy Sequenced Isolated PALND for mCRC | unknown | N/A | 39 | First Affiliated Hospital of Zhejiang UniversityOTHER | 1 | Oct 11, 2021 | clinicaltrials |
| NCT04037319 | Atrial Fibrillation After Surgery for Colorectal Cancer(AFAR) | unknown | — | 720 | Sheffield Teaching Hospitals NHS Foundation TrustOTHER | 1 | Oct 8, 2021 | clinicaltrials |
| NCT02826837 | LEAC-102 for Advanced Colorectal Cancer | unknown | Phase 1 / Phase 2 | 30 | Taiwan Leader Biotech Corp.INDUSTRY | 0 | Oct 6, 2021 | clinicaltrials |
| NCT05051592 | Role of Circulating Tumour DNA Testing in Assessing for Alterations of Primary Anti-EGFR Resistance in RAS/RAF Wild-type Metastatic Colorectal Cancer Patients | unknown | — | 40 | National University Hospital, SingaporeOTHER | 1 | Oct 5, 2021 | clinicaltrials |
| NCT01899547 | Laparoscopy-Assisted Surgery for Carcinoma of the Low Rectum(LASRE) | unknown | N/A | 1,070 | Fujian Medical UniversityOTHER | 1 | Oct 1, 2021 | clinicaltrials |
| NCT05028192 | Mitochondria Preservation by Exercise Training: a Targeted Therapy for Cancer and Chemotherapy-induced Cachexia(MEx) | unknown | — | 144 | University of Turin, ItalyOTHER | 1 | Sep 29, 2021 | clinicaltrials |
| NCT04781270 | mFOLFOXIRI+Bev vs. mFOLFOX6+Bev for RAS Mutant Unresectable Colorectal Liver-limited Metastases | unknown | Phase 3 | 308 | Fudan UniversityOTHER | 1 | Sep 27, 2021 | clinicaltrials |
| NCT04069455 | ePRO for Adjuvant Therapy of Colorectal Adenocarcinoma | unknown | N/A | 270 | Zhejiang UniversityOTHER | 1 | Sep 17, 2021 | clinicaltrials |
| NCT02948348 | Study to Nivolumab Following Preoperative Chemoradiotherapy | unknown | Phase 1 / Phase 2 | 90 | Takayuki YoshinoOTHER | 1 | Sep 16, 2021 | clinicaltrials |
Data updated 24 days agoSource updated Feb 15, 2022source: clinicaltrials